Technology News

Purchasing a laser for your practice is a significant capital investment, but when chosen wisely, it has the potential to generate a significant return. There are a number of variables to consider when differentiating between lasers and selecting the best for your practice. To begin, consider all the applications you might utilize the laser for. Wavelength is an important first decision toward meeting your needs.

WAIKOLOA, Hawaii — Ophthalmologists are using artificial intelligence and machine learning to develop programs to automate diagnoses, improve monitoring and help detect a variety of ophthalmic diseases in patients.

SAN FRANCISCO — Joel S. Schuman, MD, FACS, discusses how regenerative medicine, including the use of insulin and stem cells, is making an impact in the treatment of glaucoma at the Glaucoma 360: New Horizons Forum.

SAN FRANCISCO — Alberto Gonzalez Garcia, MD, of olleyes discusses the company’s plan to bring a virtual reality glaucoma testing platform to clinicians at Glaucoma 360: New Horizons Forum.

SAN FRANCISCO — A clinical study of NGoggle, a virtual reality device that aims to detect glaucoma, will begin at Duke University, according to a press release from the National Eye Institute, which is funding the investigation.

NEW YORK — From OSN New York 2018, Tal Raviv, MD, founder and medical director of Eye Center of New York, gives his presentation on different software and apps that will help cataract surgeons improve their practice.

Technology that can detect when nerve cells fire, which can be used to observe nerve activity in the eye as well as other light-accessible parts of the body, has been created by researchers at Stanford University, according to a press release from the National Eye Institute.

In the cover story of this issue of Ocular Surgery News, we explore the way hand-held devices are changing health care around the world, giving us access to screen millions of patients with high-tech imaging and disease monitoring at very little per-patient cost. In the third world, and even in the U.S., remote monitoring promises to shorten the distance between doctors and patients and give us unprecedented population data on disease progression.

Fundus photos are not covered by Medicare and commercial insurance carriers unless ordered to document pathology such as diabetic retinopathy, age-related macular degeneration, choroidal nevi, or vein or artery occlusion. Does a screening fundus photo in a Medicare patient require the patient to sign an Advance Beneficiary Notice that the study may not be covered by Medicare, so the patient is responsible for the charges?

Point